706 reports of this reaction
2.8% of all GLYCERIN, LIDOCAINE reports
#6 most reported adverse reaction
HERPES SIMPLEX is the #6 most commonly reported adverse reaction for GLYCERIN, LIDOCAINE, manufactured by Haleon US Holdings LLC. There are 706 FDA adverse event reports linking GLYCERIN, LIDOCAINE to HERPES SIMPLEX. This represents approximately 2.8% of all 25,225 adverse event reports for this drug.
Patients taking GLYCERIN, LIDOCAINE who experience herpes simplex should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
HERPES SIMPLEX is a less commonly reported adverse event for GLYCERIN, LIDOCAINE, but still significant enough to appear in the safety profile.
In addition to herpes simplex, the following adverse reactions have been reported for GLYCERIN, LIDOCAINE:
The following drugs have also been linked to herpes simplex in FDA adverse event reports:
HERPES SIMPLEX has been reported as an adverse event in 706 FDA reports for GLYCERIN, LIDOCAINE. This does not prove causation, but indicates an association observed in post-market surveillance data.
HERPES SIMPLEX accounts for approximately 2.8% of all adverse event reports for GLYCERIN, LIDOCAINE, making it a notable side effect.
If you experience herpes simplex while taking GLYCERIN, LIDOCAINE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.